Core Insights - Kodak reported a fourth-quarter revenue of $290 million, reflecting a 9% year-over-year increase, with growth attributed to both the Advanced Materials & Chemicals segment and the print business [2][6] - The company completed a significant pension reversion transaction, generating approximately $1.023 billion in proceeds, which reshaped its balance sheet and capital structure [4][13] - Kodak's operational EBITDA for the fourth quarter was $22 million, a 144% increase year-over-year, driven by improved pricing and higher volume [7][11] Financial Performance - Gross profit for the fourth quarter was $67 million, a 31% increase compared to the prior-year quarter, with gross margin rising to 23% from 19% [1][10] - For the full year 2025, Kodak reported consolidated revenue of $1.069 billion, a 2% increase from 2024, with gross profit improving by 14% [10][12] - On a GAAP basis, Kodak posted a net loss of $108 million for the fourth quarter and a net loss of $128 million for the full year, primarily due to pension-related expenses and debt extinguishment costs [8][12] Capital Structure and Debt Management - Kodak amended its Series B preferred equity terms, extending the redemption date to June 2029 and increasing the cumulative dividend rate to 6% [5][15] - The company utilized $312 million from pension reversion proceeds to reduce term loan principal, lowering ongoing interest expenses by approximately $40 million annually [16][17] - Kodak ended 2025 with $337 million in unrestricted cash and a net positive cash position relative to its debt obligations [14] Operational Developments - Kodak's Advanced Materials & Chemicals business experienced a 25% revenue growth in the fourth quarter, with new product launches aimed at stabilizing supply [18] - The company is focused on achieving Class II certification in its pharmaceutical initiatives and has launched four new products [19] - Continued growth in brand licensing has been noted as a significant contributor to gross profit, particularly in Asia [20]